PERMEABILITY OF THE BLOOD-BRAIN-BARRIER TO SOLUBLE CYTOKINE RECEPTORS

被引:76
作者
BANKS, WA [1 ]
PLOTKIN, SR [1 ]
KASTIN, AJ [1 ]
机构
[1] TULANE UNIV,SCH MED,NEW ORLEANS,LA 70112
关键词
INTERLEUKIN; TUMOR NECROSIS FACTOR-ALPHA; CENTRAL NERVOUS SYSTEM; TRANSPORT; BRAIN; ENDOTHELIUM; SATURABLE; MOUSE; HUMAN;
D O I
10.1159/000096887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Soluble receptors for cytokines can be important regulators of cytokine function. By binding to their cytokine ligands, they act as antagonists and carrier proteins. We investigated whether the blood-to-brain saturable transport of human tumor necrosis factor-alpha (TNF) and human interleukin-1 alpha (IL-1) radioactively labeled with I-125 could be blocked by preincubation with their soluble receptors. At ratios of 100:1 and 1,000: 1 of receptor to cytokine, the soluble p75 human receptor to TNF (rhuTNFR:Fc) totally blocked the entry of human or murine TNF into the brain. However, the soluble murine receptor to IL-1 (muIL-1R) only partially blocked IL-1 entry. Radioactively labeled rhuTNFR:Fc and muIL-1R were not transported across the blood-brain barrier (BBB) and were no more able to penetrate the BBB than the vascular marker serum albumin. This indicates that the transporter at the BBB for IL-1, but not the one for TNF, can strip the cytokine from its soluble receptor. These findings might be useful in determining which, if any, of the actions exerted on the brain by blood-borne cytokines are due to penetration of the BBB.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 50 条
  • [21] Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications
    Gao, Zhen
    Chen, Yang
    Cai, Xiaoshu
    Xu, Rong
    BIOINFORMATICS, 2017, 33 (06) : 901 - 908
  • [22] Permeability of the Blood-Brain Barrier to a Rhenacarborane
    Hawkins, Patrick M.
    Jelliss, Paul A.
    Nonaka, Naoko
    Shi, Xiaoming
    Banks, William A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (02) : 608 - 614
  • [23] A MORPHOMETRIC STUDY OF THE BLOOD-BRAIN-BARRIER IN ALZHEIMERS-DISEASE
    STEWART, PA
    HAYAKAWA, K
    AKERS, MA
    VINTERS, HV
    LABORATORY INVESTIGATION, 1992, 67 (06) : 734 - 742
  • [24] Permeability of the blood-brain barrier to neurotrophins
    Pan, WH
    Banks, WA
    Kastin, AJ
    BRAIN RESEARCH, 1998, 788 (1-2) : 87 - 94
  • [25] RECEPTOR-MEDIATED ENDOCYTOSIS OF TRANSFERRIN AT THE BLOOD-BRAIN-BARRIER
    ROBERTS, RL
    FINE, RE
    SANDRA, A
    JOURNAL OF CELL SCIENCE, 1993, 104 : 521 - 532
  • [26] OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION - CT AND RADIONUCLIDE IMAGING
    ROMANGOLDSTEIN, S
    CLUNIE, DA
    STEVENS, J
    HOGAN, R
    MONARD, J
    RAMSEY, F
    NEUWELT, EA
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1994, 15 (03) : 581 - 590
  • [27] MANGANESE NEUROTOXICITY - CELLULAR EFFECTS AND BLOOD-BRAIN-BARRIER TRANSPORT
    ASCHNER, M
    ASCHNER, JL
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1991, 15 (03) : 333 - 340
  • [28] INVIVO APPROACHES FOR STUDYING PEPTIDE INTERACTIONS AT THE BLOOD-BRAIN-BARRIER
    ZLOKOVIC, BV
    JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) : 185 - 201
  • [29] KINETICS OF ARGININE-VASOPRESSIN UPTAKE AT THE BLOOD-BRAIN-BARRIER
    ZLOKOVIC, BV
    HYMAN, S
    MCCOMB, JG
    LIPOVAC, MN
    TANG, G
    DAVSON, H
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1025 (02) : 191 - 198
  • [30] Physiological and pathological consequences of exosomes at the blood-brain-barrier interface
    Salimi, Leila
    Seyedaghamiri, Fatemehsadat
    Karimipour, Mohammad
    Mobarak, Halimeh
    Mardi, Narges
    Taghavi, Maryam
    Rahbarghazi, Reza
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)